# EDGAR Filing Document

**Accession Number:** 0001025771
**File Stem:** 0001477932-25-004994
**Filing Date:** 2025-7
**Character Count:** 50873
**Document Hash:** 96b11923d011f7c2c0676b60227ab74c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-25-004994.hdr.sgml**: 20250711

**ACCESSION NUMBER**: 0001477932-25-004994

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 43

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250711

**DATE AS OF CHANGE**: 20250711

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CHASE PACKAGING CORP
- **CENTRAL INDEX KEY:** 0001025771
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE SERVICES [0700]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 931216127
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-21609
- **FILM NUMBER:** 251119664

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 126
- **CITY:** RUMSON
- **STATE:** NJ
- **ZIP:** 07760
- **BUSINESS PHONE:** 732-741-1500

**MAIL ADDRESS:**
- **STREET 1:** PO BOX 126
- **CITY:** RUMSON
- **STATE:** NJ
- **ZIP:** 07760

?xml version='1.0' encoding='ASCII'? cpka_10q.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-Q**

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the quarterly period ended <u>June 30, 2025</u>**

**OR**

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the transition period from _________ to _________**

**Commission File Number: <u>0-21609</u>**

---

| |
|:---|
| **Chase Packaging Corporation** |
| (Exact name of registrant as specified in its charter) |

---

---

| | |
|:---|:---|
| **Delaware** | **93-1216127** |
| (State or other jurisdiction of<br>incorporation or organization) | (I.R.S. Employer<br>Identification No.) |

---

**<u>PO Box 126, Rumson NJ 07760</u>**

(Address of principal executive offices) (Zip Code)

**<u>(732) 741-1500</u>**

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer  | ☐ | Accelerated filer | ☐ |
| Non-accelerated Filer | ☒ | Smaller reporting company | ☒ |
|  |  | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes ☒ No ☐

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

---

| | |
|:---|:---|
| **Class** | **Outstanding at July 10, 2025** |
| Common Stock, par value $.00001 per share | 61,882,172 shares |

---

**Table of Contents**

**- INDEX -**

---

| | | |
|:---|:---|:---|
|  |  | **Page(s)** |
| **[PART I - Financial Information:](#P1)** | **[PART I - Financial Information:](#P1)** |  |
| [ITEM 1.](#P1I1) | [Financial Statements:](#P1I1) | 3 |
|  | [Condensed Balance Sheets (Unaudited) - June 30, 2025 and December 31, 2024](#BS) | 3 |
|  | [Condensed Statements of Operations (Unaudited) - Three and Six months ended June 30, 2025 and 2024](#SO) | 4 |
|  | [Condensed Statements of Changes in Stockholders' Equity (Unaudited) - Three and Six months ended June 30, 2025 and 2024](#SE) | 5 |
|  | [Condensed Statements of Cash Flows (Unaudited) - Six months ended June 30, 2025 and 2024](#CF) | 6 |
|  | [Notes to Interim Condensed Financial Statements (Unaudited)](#NT) | 7 |
| [ITEM 2.](#P1I2) | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#P1I2) | 11 |
| [ITEM 3.](#P1I3) | [Quantitative and Qualitative Disclosures About Market Risk](#P1I3) | 13 |
| [ITEM 4.](#P1I4) | [Controls and Procedures](#P1I4) | 14 |
| **[PART II - Other Information:](#P2)** | **[PART II - Other Information:](#P2)** |  |
| [ITEM 1.](#P2I1) | [Legal Proceedings.](#P2I1) | 15 |
| [ITEM 2.](#P2I2) | [Unregistered Sales of Equity Securities and Use of Proceeds.](#P2I2) | 15 |
| [ITEM 3.](#P2I3) | [Defaults upon Senior Securities.](#P2I3) | 15 |
| [ITEM 4.](#P2I4) | [Mine Safety Disclosures.](#P2I4) | 15 |
| [ITEM 5.](#P2I5) | [Other Information.](#P2I5) | 15 |
| [ITEM 6.](#P2I6) | [Exhibits.](#P2I6) | 15 |
| [SIGNATURES](#SIGN) | [SIGNATURES](#SIGN) | 16 |
| EXHIBITS | EXHIBITS |  |

---

---

| |
|:---|
| 2 |
| *[**Table of Contents**](#TOC)* |

---

**PART I. FINANCIAL INFORMATION**

**Item 1. Financial Statements.**

 **CHASE PACKAGING CORPORATION**

**CONDENSED BALANCE SHEETS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **June 30,**<br>**2025** | **December 31,** <br>**2024** |
| **CURRENT ASSETS:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $253317 | $297710 |
| **TOTAL ASSETS** | $253317 | $297710 |
| **LIABILITIES AND STOCKHOLDERS' EQUITY**  | **LIABILITIES AND STOCKHOLDERS' EQUITY**  | **LIABILITIES AND STOCKHOLDERS' EQUITY**  |
| **CURRENT LIABILITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $3473 | $3473 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL CURRENT LIABILITIES** | 3473 | 3473 |
| **COMMITMENTS AND CONTINGENCIES (Note 8)** |  |  |
| **STOCKHOLDERS' EQUITY:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock, $1.00 par value; 4,000,000 authorized: Series A 10% Convertible preferred stock; 50,000 shares designated; no shares issued and outstanding at June 30, 2025 and December 31, 2024 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.00001 par value; 200,000,000 shares authorized; 62,379,759 shares issued and 61,882,172 shares outstanding at June 30, 2025 and December 31, 2024 | 619 | 619 |
| &nbsp;&nbsp;&nbsp;&nbsp;Treasury stock, $0.00001 par value 497,587 shares at June 30, 2025 and December 31, 2024 | (49759) | (49759) |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital  | 8839367 | 8839367 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit  | (8540383) | (8495990) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL STOCKHOLDERS' EQUITY** | 249844 | 294237 |
| **TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY** | $253317 | $297710 |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 3 |
| *[**Table of Contents**](#TOC)* |

---

**CHASE PACKAGING CORPORATION**

**CONDENSED STATEMENTS OF OPERATIONS**

**(Unaudited)**

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** | **Six Months Ended** | **Six Months Ended** |
|  | **June 30,** | **June 30,** | **June 30,** | **June 30,** |
|  | **2025** | **2024** | **2025** | **2024** |
| **EXPENSES:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;General and administrative expense | 32456 | 27553 | 49781 | 66690 |
| **LOSS FROM OPERATIONS** | (32456) | (27553) | (49781) | (66690) |
| **OTHER INCOME (EXPENSE)** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Interest and other income | 2570 | 4192 | 5388 | 8058 |
| **TOTAL OTHER INCOME (EXPENSE)** | 2570 | 4192 | 5388 | 8058 |
| **LOSS BEFORE INCOME TAXES** | (29886) | (23361) | (44393) | (58632) |
| &nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes |  |  |  |  |
| **NET LOSS** | $(29886) | $(23361) | $(44393) | $(58632) |
| **BASIC AND DILUTED LOSS PER COMMON SHARE** | $(0.00) | $(0.00) | $(0.01) | $(0.00) |
| **BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING** | 61882172 | 61882172 | 61882172 | 61882172 |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 4 |
| *[**Table of Contents**](#TOC)* |

---

**CHASE PACKAGING CORPORATION**

**CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY**

**(Unaudited)**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **FOR THE THREE ENDED JUNE 30, 2025**  | **FOR THE THREE ENDED JUNE 30, 2025**  | **FOR THE THREE ENDED JUNE 30, 2025**  | **FOR THE THREE ENDED JUNE 30, 2025**  | **FOR THE THREE ENDED JUNE 30, 2025**  | **FOR THE THREE ENDED JUNE 30, 2025**  | **FOR THE THREE ENDED JUNE 30, 2025**  | **FOR THE THREE ENDED JUNE 30, 2025**  |
|  | **Common** | **Common** | | | **Treasury Stock** | **Treasury Stock** | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Accumulated**<br>**Deficit** | **Shares** | **Amount** | <br><br>**Total** |
| Balance at March 31, 2025 | 62379759 | $619 | $8839367 | $(8510497) | (497587) | $(49759) | $279730 |
| Net loss for the three months ended June 30, 2025 |  |  |  | (29886) |  |  | (29886) |
| Balance at June 30, 2025 | 62379759 | $619 | $8839367 | $(8540383) | (497587) | $(49759) | $249844 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **FOR THE SIX ENDED JUNE 30, 2025** | **FOR THE SIX ENDED JUNE 30, 2025** | **FOR THE SIX ENDED JUNE 30, 2025** | **FOR THE SIX ENDED JUNE 30, 2025** | **FOR THE SIX ENDED JUNE 30, 2025** | **FOR THE SIX ENDED JUNE 30, 2025** | **FOR THE SIX ENDED JUNE 30, 2025** | **FOR THE SIX ENDED JUNE 30, 2025** |
|  | **Common** | **Common** | | | **Treasury Stock** | **Treasury Stock** | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Accumulated**<br>**Deficit** | **Shares** | **Amount** | <br><br>**Total** |
| Balance at December 31, 2024 | 62379759 | $619 | $8839367 | $(8495990) | (497587) | $(49759) | $294237 |
| Net loss for the six months ended June 30, 2025 |  |  |  | (44393) |  |  | (44393) |
| Balance at June 30, 2025 | 62379759 | $619 | $8839367 | $(8540383) | (497587) | $(49759) | $249844 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **FOR THE THREE ENDED JUNE 30, 2024** | **FOR THE THREE ENDED JUNE 30, 2024** | **FOR THE THREE ENDED JUNE 30, 2024** | **FOR THE THREE ENDED JUNE 30, 2024** | **FOR THE THREE ENDED JUNE 30, 2024** | **FOR THE THREE ENDED JUNE 30, 2024** | **FOR THE THREE ENDED JUNE 30, 2024** | **FOR THE THREE ENDED JUNE 30, 2024** |
|  | **Common** | **Common** | | | **Treasury Stock** | **Treasury Stock** | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Accumulated**<br>**Deficit** | **Shares** | **Amount** | <br><br>**Total** |
| Balance at March 31, 2024 | 62379759 | $619 | $8839367 | $(8442312) | (497587) | $(49759) | $347915 |
| Net loss for the three months ended June 30, 2024 |  |  |  | (23361) |  |  | (23361) |
| Balance at June 30, 2024 | 62379759 | $619 | $8839367 | $(8465673) | (497587) | $(49759) | $324554 |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **FOR THE SIX ENDED JUNE 30, 2024** | **FOR THE SIX ENDED JUNE 30, 2024** | **FOR THE SIX ENDED JUNE 30, 2024** | **FOR THE SIX ENDED JUNE 30, 2024** | **FOR THE SIX ENDED JUNE 30, 2024** | **FOR THE SIX ENDED JUNE 30, 2024** | **FOR THE SIX ENDED JUNE 30, 2024** | **FOR THE SIX ENDED JUNE 30, 2024** |
|  | **Common** | **Common** | | | **Treasury Stock** | **Treasury Stock** | |
|  | **Shares** | **Amount** | **Additional**<br>**Paid-in**<br>**Capital** | <br>**Accumulated**<br>**Deficit** | **Shares** | **Amount** | <br><br>**Total** |
| Balance at December 31, 2023 | 62379759 | $619 | $8839367 | $(8407041) | (497587) | $(49759) | $383186 |
| Net loss for the six months ended June 30, 2024 |  |  |  | (58632) |  |  | (58632) |
| Balance at June 30, 2024 | 62379759 | $619 | $8839367 | $(8465673) | (497587) | $(49759) | $324554 |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 5 |
| *[**Table of Contents**](#TOC)* |

---

**CHASE PACKAGING CORPORATION**

**CONDENSED STATEMENTS OF CASH FLOWS**

**(Unaudited)**

---

| | | |
|:---|:---|:---|
|  | **For The Six Months Ended**  | **For The Six Months Ended**  |
|  | **June 30,** | **June 30,** |
|  | **2025** | **2024** |
| **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net Loss | $(44393) | (58632) |
| Adjustments to reconcile net loss from operations to net cash used in operating activities: |  |  |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities |  | (1634) |
| **Net cash used in operating activities** | (44393) | (60266) |
| **CASH FLOWS FROM INVESTING ACTIVITIES** |  |  |
| **CASH FLOWS FROM FINANCING ACTIVITIES** |  |  |
| **NET DECREASE IN CASH**  | (44393) | (60266) |
| Cash, Beginning of Period | 297710 | 388171 |
| **CASH, END OF PERIOD** | $253317 | $327905 |
| **SUPPLEMENTAL CASH FLOW INFORMATION:** |  |  |
| Cash paid for: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Interest paid | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;Income taxes paid | $— | $— |

---

The accompanying notes are an integral part of these unaudited condensed financial statements.

---

| |
|:---|
| 6 |
| *[**Table of Contents**](#TOC)* |

---

**CHASE PACKAGING CORPORATION**

**NOTES TO THE CONDENSED FINANCIAL STATEMENTS**

**(UNAUDITED)**

**JUNE 30, 2025** 

**NOTE 1 - BASIS OF PRESENTATION:**

Chase Packaging Corporation ("the Company"), a Delaware Corporation, previously manufactured woven paper mesh for industrial applications and polypropylene mesh fabric bags for agricultural use, and distributed agricultural packaging manufactured by other companies. Management's plans for the Company include securing a merger or acquisition, raising additional capital, and other strategies designed to optimize shareholder value. However, no assurance can be given that management will be successful in its efforts. The failure to achieve these plans will have a material adverse effect on the Company's financial position, results of operations, and ability to continue as a going concern.

The unaudited condensed financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC"). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles ("U.S. GAAP") have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to provide for fair presentation and a reasonable understanding of the information presented. The unaudited condensed financial statements should be read in conjunction with the financial statements and the related notes, as well as Management's Discussion and Analysis of Financial Condition and Results of Operations, included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, previously filed with the SEC.

In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair statement of financial position as of June 30, 2025, and results of operations and cash flows for the six months ended June 30, 2025 and 2024, as applicable, have been made. The results of operations for the six months ended June 30, 2025 are not necessarily indicative of the operating results for the full fiscal year ended December 31, 2024 or any future periods.

**NOTE 2 - LIQUIDITY**:

At June 30, 2025 and December 31, 2024, the Company had cash and cash equivalents of $253,317 and $297,710, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the six months ended June 30, 2025 and 2024, amounted to $44,393 and $58,632, respectively, and we had working capital of $249,844 and $294,237 at June 30, 2025 and December 31, 2024, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

**NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS:**

***Use of Estimates***

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

***Cash and Cash Equivalents***

The Company considers all highly liquid investments that are readily convertible into cash with a remaining maturity of three months or less at the time of acquisition to be cash equivalents. The Company maintains its cash and cash equivalents balances with high credit quality financial institutions. As of June 30, 2025 and December 31, 2024, the Company had cash in insured accounts in the amount of $2,341 and $2,622, respectively, and cash equivalents (Treasury and government securities) held in financial institutions that were uninsured by Federal Deposit Insurance Corporation in the amount of $250,976 and $295,088, respectively.

***Income Taxes***

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carry forwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured assuming enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless it is more likely than not that such asset will be realized.

---

| |
|:---|
| 7 |
| *[**Table of Contents**](#TOC)* |

---

The Company follows FASB Interpretation of "Accounting for Uncertainty in Income Taxes." At June 30, 2025 and December 31, 2024, the Company evaluated its tax positions and did not have any unrecognized tax benefits. The Company's practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company currently has no federal or state tax examinations in progress.

***Accounting for Stock Based Compensation***

Stock-based compensation expense incurred by the Company for employees and directors is based on the employee model of ASC 718, and the fair market value of the award is measured at the grant date. Under ASC 718 employee is defined as "An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. "tax regulations." Our consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 718 as amended by ASU 2018-07. As such, the grant date is the measurement date of an award's fair value. Corresponding expenses for employee and non-employee services are recognized over the requisite service period, which is typically the vesting period.

***Treasury Stock***

The Company accounts for treasury stock using the cost method. There were 497,587 shares of Class A common stock held in treasury, purchased at a total cumulative cost of approximately $49,759, as of June 30, 2025 and December 31, 2024.

***Recently Adopted Accounting Pronouncements***

The FASB issued ASU No. 2016-13, *Financial Instruments - Credit Losses (Topic 326)*. This standard requires a financial asset to be presented at the net amount expected to be collected. We expect the financial assets of the Company in scope of ASU 2016-13 will primarily be accounts receivable. The Company will estimate an allowance for expected credit losses on accounts receivable that result from the inability of customers to make required payments. In estimating the allowance for expected credit losses, consideration will be given to the current aging of receivables, historical experience, and a review for potential bad debts. The Company adopted this guidance in the second quarter of fiscal 2023 and it did not have a material impact on its results of operations, financial position, and disclosures.

In November 2023, the FASB issued ASU 2023-07, S*egment Reporting (Topic 280)*: *Improvements to Reportable Segment Disclosures.* The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. This ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company adopted the ASU and determined that its adoption did not have a material impact on the Company's consolidated financial statements and related disclosures. As defined in the ASU, operating segments are components of an enterprise about which discrete financial information is regularly provided to the CODM in making decisions on how to allocate resources and assess performance for the organization. The Company operates and manages its business as one reportable and operating segment. The Company's CODM is the Chief Executive Officer. The Company's CODM reviews consolidated operating results to make decisions about allocating resources and assessing performance for the entire Company.

ASU No. 2023-09, *Income Taxes (Topic 740): Improvements to Income Tax Disclosures*, was issued by the FASB in December 2023. This guidance enhances income tax disclosure requirements by mandating the disclosure of (1) specific categories in the rate reconciliation, (2) income or loss from continuing operations before income taxes, disaggregated between domestic and foreign, and (3) income tax expense or benefit from continuing operations, disaggregated by federal, state, and foreign. The ASU also requires disclosure of income tax payments to federal, state, local, and foreign jurisdictions, among other changes. The standard is effective for annual periods beginning after December 15, 2024, and will be adopted by the Company as permitted. The Company will apply the guidance on a prospective basis and the adoption is not expected to have a material impact on its condensed financial statements or related disclosures.

The Company does not believe that other standards, which have been issued but are not yet effective, will have a significant impact on its financial statements.

**NOTE 4 - BASIC AND DILUTED NET LOSS PER COMMON SHARE:**

Basic loss per common share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding. Diluted loss per share is computed by dividing the net loss by the sum of the weighted-average number of shares of common stock outstanding plus the dilutive effect of shares issuable through the exercise of common stock equivalents.

---

| |
|:---|
| 8 |
| *[**Table of Contents**](#TOC)* |

---

We have excluded 6,909,000 common stock equivalents (warrants - Note 5) from the calculation of diluted loss per share for the three months ended June 30, 2025 and 2024, respectively, which, if included, would have an antidilutive effect.

**NOTE 5 - WARRANTS AND PREFERRED STOCKS:**

**Warrants**

2023 Extension of Warrant Terms

The Company, acting by resolution of its Board of Directors, amended and extended the expiration date of its outstanding warrants to purchase up to 6,909,000 shares of common stock to March 7, 2026. The terms of the warrants, including the exercise price of $0.15 per share, remain in effect without modification. The warrants modification expense of $345,450 was recorded as the incremental value of the modified warrants over the unmodified warrants on the modification date. Assumptions used in the Black Scholes option-pricing model for these warrants were as follows:

---

| | |
|:---|:---|
| Average risk-free interest rate | 4.66% |
| Average expected life-years | 3.0 |
| Expected volatility | 182.19% |
| Expected dividends | 0.0% |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **Number of**<br>**Warrants** | **Weighted**<br>**Average**<br>**Exercise**<br>**Price** | **Weighted Average**<br>**Remaining Contractual**<br>**Life (Years)** |
| Outstanding at December 31, 2024 | 6909000 | $0.15 | 1.18 |
| &nbsp;&nbsp;&nbsp;&nbsp;Granted |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Extended |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Exercised |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Forfeited/expired | - | - | - |
| Outstanding at June 30, 2025 | 6909000 | $0.15 | 0.68 |
| Exercisable at June 30, 2025 | 6909000 | $0.15 | 0.68 |

---

As of June 30, 2025 and December 31, 2024, the average remaining contractual life of the outstanding warrants was 0.68 years and 1.18 year, respectively. The warrants will expire on March 7, 2026. The intrinsic value of the warrants at June 30, 2025 was $0.

**Series A 10% Convertible Preferred Stock** 

The Company has authorized 4,000,000 shares of Preferred Stock, of which 50,000 shares have been designated as Series A 10% Convertible Preferred Stock. As of June 30, 2025 and December 31, 2024, there was no preferred stock issued or outstanding.

**NOTE 6 - STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION:**

At June 30, 2025 and December 31, 2024, the Company had 61,882,172 common shares outstanding. Also outstanding were warrants relating to 6,909,000 shares of common stock, all totaling 68,791,172 shares of common stock and all common stock equivalents, outstanding at June 30, 2025 and December 31, 2024.

The Company did not incur any stock-based compensation or issue common or preferred stock or any other equity instruments during the three months ended June 30, 2025 and 2024.

---

| |
|:---|
| 9 |
| *[**Table of Contents**](#TOC)* |

---

**NOTE 7 - FAIR VALUE MEASUREMENTS:**

ASC 820, "Fair Value Measurements and Disclosure," ("ASC 820") defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

The three levels are described below:

Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;

Level 2 Inputs - Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly;

Level 3 Inputs - Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants.

There were no transfers in or out of any level during the six months ended June 30, 2025 or 2024.

Except for those assets and liabilities which are required by authoritative accounting guidance to be recorded at fair value in the Company's balance sheets, the Company has elected not to record any other assets or liabilities at fair value, as permitted by ASC 820. No events occurred during the six months ended June 30, 2025 or 2024 which would require adjustment to the recognized balances of assets or liabilities which are recorded at fair value on a nonrecurring basis.

The Company determines fair values for its investment assets as follows:

Cash equivalents at fair value - the Company's cash equivalents, at fair value, consist of money market funds - marked to market on reporting dates. The Company's money market funds are classified within Level 1 of the fair value hierarchy since they are valued using quoted market prices from an exchange.

The following tables provide information on those assets measured at fair value on a recurring basis as of June 30, 2025 and December 31, 2024, respectively:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | | **Fair Value Measurement Using** | **Fair Value Measurement Using** | **Fair Value Measurement Using** |
|  | **Carrying**<br>**Amount In**<br>**Balance Sheet**<br>**June 30,**<br>**2025** | **Fair Value**<br>**June 30,**<br>**2025** | **Level 1** | **Level 2** | **Level 3** |
| **Assets:** |  |  |  |  |  |
| Treasury Bills | $250976 | $250976 | $250976 | $— | $— |
| Money Market Funds | 2341 | 2341 | 2341 |  |  |
| Total Assets | $253317 | $253317 | $253317 | $— | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | | **Fair Value Measurement Using** | **Fair Value Measurement Using** | **Fair Value Measurement Using** |
|  | **Carrying**<br>**Amount In**<br>**Balance Sheet**<br>**June 30,**<br>**2024** | **Fair Value**<br>**June 30,**<br>**2024** | **Level 1** | **Level 2** | **Level 3** |
| **Assets:** |  |  |  |  |  |
| Treasury Bills | $295088 | $295088 | $295088 | $— | $— |
| Money Market Funds | 2622 | 2622 | 2622 |  |  |
| Total Assets | $297710 | $297710 | $297710 | $— | $— |

---

**NOTE 8 - COMMITMENTS AND CONTINGENCIES:**

The Company's Board of Directors has agreed to pay the Company's Chief Financial Officer an annual salary of $17,000. No other officers or directors of the Company receive cash compensation other than reimbursement of out-of-pocket expenses incurred in connection with Company business and development.

**NOTE 9 - SUBSEQUENT EVENTS:**

The Company has evaluated subsequent events from June 30, 2025 through the issuance date of these financial statements, and there are no events requiring disclosure.

---

| |
|:---|
| 10 |
| *[**Table of Contents**](#TOC)* |

---

**Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.**

**Forward-Looking Statements**

*The information in this report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This Act provides a "safe harbor" for forward-looking statements to encourage companies to provide prospective information about themselves provided they identify these statements as forward looking and provide meaningful cautionary statements identifying important factors that could cause actual results to differ from the projected results. All statements other than statements of historical fact made in this report are forward-looking. In particular, the statements herein regarding future results of operations or financial position are forward-looking statements. Forward-looking statements reflect management's current expectations and are inherently uncertain. The Company's actual results may differ significantly from management's expectations as a result of many factors.*

*You should read the following discussion and analysis in conjunction with the financial statements of the Company, and notes thereto, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of management. The Company assumes no obligations to update any of these forward-looking statements.*

**Results of Operations**

***<u>For the three months ended June 30, 2025 and 2024</u>***

**Revenue** 

The Company had no operations and no revenue for the three months ended June 30, 2025 and 2024, and its only income was from interest income on its short-term investments which are classified as cash and cash equivalents.

**Operating Expenses**

The following table presents our total operating expenses for the three months ended June 30, 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended**<br>**June 30,** | **Three Months Ended**<br>**June 30,** |
|  | **2025** | **2024** |
| Audit and accounting fees | $9600 | $21970 |
| Payroll expense | 5147 | 4987 |
| Other general and administrative expense  | 17709 | 596 |
|  | $32456 | $27553 |

---

Operating expenses increased by $4,903 for the three months ended June 30, 2025 as compared to the three months ended June 30, 2024. The increase was related to the increase in other general and administrative expenses offset by a decrease in legal and professional fees for the three months ended June 30, 2025.

Other general and administrative expenses are comprised of OTC registration fee, transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.

**Loss from Operations**

The Company incurred a loss from operations of $32,456 and $27,553 for the three months ended June 30, 2025 and 2024, respectively.

**Other Income (Expense)**

The following table presents our total Other Income (Expense) for the three months ended June 30, 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended**<br>**June 30,** | **Three Months Ended**<br>**June 30,** |
|  | **2025** | **2024** |
| Interest and other income | $2570 | $4192 |
| Other Income (Expense), net | $2570 | $4192 |

---

---

| |
|:---|
| 11 |
| *[**Table of Contents**](#TOC)* |

---

Other income decreased by $1,622 for the six months ended June 30, 2025 as compared to the three months ended June 30, 2024. This decrease primarily resulted from a lower bank balance during the three months ended June 30, 2025.

**Net Loss**

The Company had a net loss of $29,886 for the three months ended June 30, 2025, compared with a net loss of $23,361 for the three months ended June 30, 2024. The increase in net loss was due to the above-mentioned effect of Other general and administrative expense.

Loss per share for the three months ended June 30, 2025 and 2024 was approximately $(0.00) and $(0.00) based on the weighted-average shares issued and outstanding.

It is anticipated that future operating expenses will decrease and then stabilize as the Company complies with its periodic reporting requirements; however, expenses may increase as the Company works to effect a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.

***<u>For the six months ended June 30, 2025 and 2024</u>***

**Revenue** 

The Company had no operations and no revenue for the six months ended June 30, 2025 and 2024, and its only income was from interest income on its short-term investments which are classified as cash and cash equivalents.

**Operating Expenses**

The following table presents our total operating expenses for the six months ended June 30, 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended**<br>**June 30,** | **Six Months Ended**<br>**June 30,** |
|  | **2025** | **2024** |
| Audit and accounting fees | $18845 | $48859 |
| Payroll expense | 10431 | 10267 |
| Other general and administrative expense  | 20505 | 7564 |
|  | $49781 | $66690 |

---

Operating expenses decreased by $16,909 for the six months ended June 30, 2025 as compared to the six months ended June 30, 2024. The decrease was related to the decrease in legal and professional fees for the six months ended June 30, 2025.

Other general and administrative expenses are comprised of OTC registration fee, transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.

**Loss from Operations**

The Company incurred a loss from operations of $49,781 and $66,690 for the six months ended June 30, 2025 and 2024, respectively.

**Other Income (Expense)**

The following table presents our total Other Income (Expense) for the six months ended June 30, 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended**<br>**June 30,** | **Six Months Ended**<br>**June 30,** |
|  | **2025** | **2024** |
| Interest and other income | $5388 | $8058 |
| Other Income (Expense), net | $5388 | $8058 |

---

Other income decreased by $2,670 for the six months ended June 30, 2025 as compared to the six months ended June 30, 2024. This decrease primarily resulted from a lower bank balance during the six months ended June 30, 2025.

---

| |
|:---|
| 12 |
| *[**Table of Contents**](#TOC)* |

---

**Net Loss**

The Company had a net loss of $44,393 for the six months ended June 30, 2025, compared with a net loss of $58,632 for the six months ended June 30, 2024. The decrease in net loss was due to the above-mentioned effect of legal and professional fees expense.

Loss per share for the six months ended June 30, 2025 and 2024 was approximately $(0.00) and $(0.00) based on the weighted-average shares issued and outstanding.

It is anticipated that future operating expenses will decrease and then stabilize as the Company complies with its periodic reporting requirements; however, expenses may increase as the Company works to effect a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.

**Liquidity and Capital Resources**

At June 30, 2025 the Company had cash and cash equivalents of $253,317, consisting of money market funds and U.S. Treasury and government securities maturing in 3 months or less. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

The following table provides detailed information about our net cash flow for all years presented in this Report.

**Cash Flow**

---

| | | |
|:---|:---|:---|
|  | **Six Months Ended**<br>**June 30,** | **Six Months Ended**<br>**June 30,** |
|  | **2025** | **2024** |
| Net cash used in operating activities | $(44393) | $(60266) |
| Net cash provided by investing activities |  |  |
| Net cash provided by financing activities |  |  |
| Net cash outflow  | $(44393) | $(60266) |

---

Net cash of $44,393 and $60,266 were used in operations during the six months ended June 30, 2025 and 2024, respectively.

The cash used in operating activities of $44,393 for the six months ended June 30, 2025 principally resulted from our net loss of $44,393.

The cash used in operating activities of $60,266 for the six months ended June 30, 2024 principally resulted from our net loss of $58,632 and change in accounts payable and accrued expenses of $1,634.

No cash flows were used in or provided by investing activities during the six months ended June 30, 2025 and 2024.

No cash flows were used in or provided by financing activities during the six months ended June 30, 2025 and 2024.

**New Accounting Pronouncements**

Refer to the discussion of recently adopted/issued accounting pronouncements under Note 3 - Significant Accounting Policies and Recent Accounting Pronouncements.

**Factors Which May Affect Future Results**

Future earnings of the Company are dependent on interest rates earned on the Company's invested balances and expenses incurred. The Company expects to incur significant expenses in connection with its objective of identifying a merger partner or acquiring an operating business.

**Item 3. Quantitative and Qualitative Disclosures About Market Risk.**

Not applicable.

---

| |
|:---|
| 13 |
| *[**Table of Contents**](#TOC)* |

---

**Item 4. Controls and Procedures.**

**Evaluation of Disclosure Controls and Procedures.**

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures. The term "disclosure controls and procedures," as defined in Rules 13a-15I and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports, such as this report, that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on that evaluation, our chief executive officer and chief financial officer concluded that as of June 30, 2025, our disclosure controls and procedures were effective.

**Changes in Internal Controls over Financial Reporting.**

We regularly review our system of internal control over financial reporting.

During the quarter ended June 30, 2025, there were no changes in our internal controls over financial reporting that have materially affected, or are reasonably likely to affect materially, our internal control over financial reporting.

---

| |
|:---|
| 14 |
| *[**Table of Contents**](#TOC)* |

---

**PART II. OTHER INFORMATION**

**Item 1. Legal Proceedings.**

None.

**Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.**

None.

**Item 3. Defaults upon Senior Securities.**

None.

**Item 4. Mine Safety Disclosures.**

Not applicable.

**Item 5. Other Information.**

None.

**Item 6. Exhibits.**

---

| | |
|:---|:---|
| **Number** | **Description** |
| [31.1\*](cpka_ex311.htm) | [Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](cpka_ex311.htm) |
| [32.1\*](cpka_ex321.htm) | [Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](cpka_ex321.htm) |
| 101.INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Labels Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |

---

_____________

\* Filed herewith

---

| |
|:---|
| 15 |
| *[**Table of Contents**](#TOC)* |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **CHASE PACKAGING CORPORATION** | **CHASE PACKAGING CORPORATION** |
| Date: July 11, 2025 | By: | */s/ Ann C. W. Green* |
|  |  | Ann C. W. Green |
|  |  | Chief Financial Officer and Assistant Secretary |
|  |  | (Principal Executive, Financial and Accounting Officer) |

---

## Exhibit 31.1

**EXHIBIT 31.1**

**CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER**

**PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002**

I, Ann C. W. Green, certify that:

1. I have reviewed this report on Form 10-Q of Chase Packaging Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c. Evaluated the effectiveness of the registrant s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and

d. Disclosed in this report any change in the registrant s internal control over financial reporting that occurred during the registrant s most recent fiscal quarter (the registrant s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant s internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant s auditors and the audit committee of the registrant s board of directors (or persons performing the equivalent functions):

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant s ability to record, process, summarize, and report financial information; and

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant s internal control over financial reporting.

---

| | | |
|:---|:---|:---|
| Date: July 11, 2025 | By: | */s/ Ann C. W. Green* |
|  |  | Ann C. W. Green |
|  |  | Chief Financial Officer and Assistant Secretary |
|  |  | (Principal Executive, Financial and Accounting Officer) |

---

## Exhibit 32.1

**EXHIBIT 32.1**

**CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Chase Packaging Corporation (the "Company"), does hereby certify, to such officer s knowledge, that:

The Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the "Form 10-Q") of the Company fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company as of, and for, the periods presented in the Form 10-Q.

The foregoing certification is being furnished as an exhibit to the Form 10-Q pursuant to Item 601(b)(32) of Regulation S-K and Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and, accordingly, is not being filed as part of the Form 10-Q for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

---

| | | |
|:---|:---|:---|
| Date: July 11, 2025 | By: | */s/ Ann C. W. Green* |
|  |  | Ann C. W. Green |
|  |  | Chief Financial Officer and Assistant Secretary |
|  |  | (Principal Executive, Financial and Accounting Officer) |

---